First‐In‐Human Safety, Pharmacokinetics, and Pharmacodynamics of VENT‐02 Freebase, a CNS‐Penetrant NLRP3 Inhibitor.

Saved in:
Bibliographic Details
Title: First‐In‐Human Safety, Pharmacokinetics, and Pharmacodynamics of VENT‐02 Freebase, a CNS‐Penetrant NLRP3 Inhibitor.
Authors: Smidt, Lisanne C. A.1,2 (AUTHOR), Moerland, Matthijs1,2 (AUTHOR), Jansen, Manon A. A.1,2 (AUTHOR), Kremer, Philip H. C.1,2 (AUTHOR), Sille, Alexandra A. J.1,2 (AUTHOR), Strugala, Pamela K.1 (AUTHOR), Klaassen, Erica S.1 (AUTHOR), Auger, Anick3 (AUTHOR), Jananji, Silvana3 (AUTHOR), Faidi, Rania3 (AUTHOR), Pike, Kelly A.3 (AUTHOR), Warner, Loraine4 (AUTHOR), Matta, Andre4 (AUTHOR), Valencia, Xavier4 (AUTHOR), Spiegelstein, Ofer4 (AUTHOR) ospiegelstein@gmail.com
Source: CTS: Clinical & Translational Science. May2026, Vol. 19 Issue 5, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17528054
DOI:10.1111/cts.70578